https://www.selleckchem.com/products/cc-92480.html
FoxM1 might be a key switch for activating β-catenin pathway and renal fibrosis. Therefore, FoxM1 might be a potential therapeutic target in manipulating renal fibrosis. Thymectomy is required for the treatment of thymoma-associated myasthenia gravis (MG). However, MG may develop only after thymectomy, a condition known as post-thymectomy MG. This study aimed to investigate the risk factors for post-thymectomy MG in patients with thymoma. We retrospectively identified 235 patients with thymoma who underwent thymectomy at a single hospi
Aimer
Commentaire
Partagez
